CVE-2026-54215: Tobit Laboratories AG TeamDavid's Webbox contains an open redirect vulnerability via the “replyUrl”
Source GCVE Database
Not known to be exploited · CVSS 5.3 Medium : upgrade to Rollout 528 when convenient.
Data as of 26 Oct 2026, 13:47 UTC
- EPSS
- 0.4% chance of exploitation in 30 days – higher than 39% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in Rollout 528
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 7 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Upgrade TeamDavid to Rollout 528.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Tobit Laboratories AGTeamDavid | Affected
| Fixed in
|
Description
Tobit Laboratories AG TeamDavid's Webbox contains an open redirect vulnerability via the “replyUrl” parameter. An attacker can exploit this vulnerability to craft a URL within the application that, when visited, redirects the user’s browser to an arbitrary third-party site. This can be abused for phishing attacks, where users receive a trusted domain link but are redirected to a phishing website. This issue affects TeamDavid through Rollout 524.